% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • settoplunge settoplunge May 18, 2013 9:16 PM Flag

    ProNeura for Parkinson's

    Another company is developing a two month slow release implant of a generic dopamine agonist to treat Parkinson's.

    Per their 10K: they held a meeting with the FDA and "based on this meeting, we believe that we can submit an NDA under Section 505(b)(2) of the FDCA and that the FDA may require only a single successful pivotal Phase III clinical trial for approval."

    Can Titan run one P3 trial to get their ProNeura implant approved?
    What is Sunil waiting for?
    Titan has $17 million. Why not advance the Parkinson's program?
    He will burn all the cash in a year and shareholders will have nothing to show for it.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.99-0.07(-1.38%)Oct 20 4:00 PMEDT